Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Gastric cancer in Japan

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 23.07.12
Views: 23501

Dr Takeshi Sano - National Cancer Centre Hospital, Tokyo, Japan

Mortality from gastric cancer is the second highest of all cancers within Japan, and the increasing age and weight of the Japanese population makes surgery to treat this cancer progressively more difficult. Dr Takeshi Sano discusses D2 lymphadenectomy, a lymph node dissection procedure that has been developed in Japan for the treatment of gastric cancer and suggests reasons for the high level of geographic homogeneity seen in global gastric cancer treatment outcomes.


This programme was supported by BAYER.


Colorectal & gastro · Surgery · WCGC 14

Related videos

follow us

Donate to ecancer

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation